Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$709M |
| 2 |
Amazon
AMZN
|
+$653M |
| 3 |
Tesla
TSLA
|
+$457M |
| 4 |
Exxon Mobil
XOM
|
+$450M |
| 5 |
Uber
UBER
|
+$382M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$520M |
| 2 |
Netflix
NFLX
|
+$476M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$377M |
| 5 |
Apple
AAPL
|
+$374M |
Sector Composition
| 1 | Technology | 19.76% |
| 2 | Healthcare | 17.68% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Industrials | 7.95% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3201
SES AI
SES
$424M
| $159K | ﹤0.01% |
86,900
-61,195
| -41% | -$112K |
|
|
AEVA
3202
Aeva Technologies
AEVA
$893M
| $157K | ﹤0.01% |
41,420
+36,880
| +812% | +$140K |
|
3203
CuriosityStream
CURI
$261M
| $157K | ﹤0.01% |
290,100
+17,200
| +6% | +$9.31K |
|
3204
Superior Group of Companies
SGC
$196M
| $157K | ﹤0.01% |
11,600
-35,100
| -75% | -$475K |
|
|
GGE
3205
DELISTED
Green Giant Inc. Common Stock
GGE
| $155K | ﹤0.01% |
+2,970,340
| New | +$155K |
|
|
ENFN
3206
DELISTED
Enfusion, Inc.
ENFN
| $155K | ﹤0.01% |
+16,000
| New | +$155K |
|
3207
Cogent Biosciences
COGT
$1.79B
| $154K | ﹤0.01% |
+26,268
| New | +$154K |
|
3208
The Beachbody Company, Inc. Class A Common Stock
BODI
$42.3M
| $153K | ﹤0.01% |
18,464
+4,846
| +36% | +$40.2K |
|
|
HOOK
3209
DELISTED
HOOKIPA Pharma
HOOK
| $153K | ﹤0.01% |
18,865
-36,699
| -66% | -$298K |
|
|
NCNA
3210
NuCana
NCNA
$7M
| $153K | ﹤0.01% |
104
+33
| +46% | +$48.5K |
|
3211
Zymeworks
ZYME
$1.24B
| $153K | ﹤0.01% |
14,700
-1,158
| -7% | -$12.1K |
|
3212
Direxion Daily Dow Jones Internet Bear 3X Shares
WEBS
$6.22M
| $152K | ﹤0.01% |
+1,780
| New | +$152K |
|
3213
DarioHealth
DRIO
$17M
| $151K | ﹤0.01% |
4,400
+545
| +14% | +$18.7K |
|
|
AHG
3214
Akso Health Group
AHG
$1.01B
| $149K | ﹤0.01% |
201,898
+2,500
| +1% | +$1.85K |
|
3215
Traws Pharma
TRAW
$12.8M
| $148K | ﹤0.01% |
7,954
+606
| +8% | +$11.3K |
|
3216
Daxor
DXR
$55.4M
| $147K | ﹤0.01% |
15,321
-500
| -3% | -$4.8K |
|
|
TAOX
3217
Tao Synergies Inc. Common Stock
TAOX
$21.5M
| $147K | ﹤0.01% |
21,635
+20,703
| +2,221% | +$141K |
|
|
EAR
3218
DELISTED
Eargo, Inc. Common Stock
EAR
| $147K | ﹤0.01% |
56,580
+8,600
| +18% | +$22.3K |
|
|
AMBR
3219
Amber International Holding Limited American Depositary Shares
AMBR
$393M
| $146K | ﹤0.01% |
38,143
| – | – |
|
3220
Rani Therapeutics
RANI
$24.2M
| $145K | ﹤0.01% |
43,700
-7,300
| -14% | -$24.2K |
|
|
HARP
3221
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $145K | ﹤0.01% |
12,756
-12,100
| -49% | -$138K |
|
3222
American Express Global Business Travel
GBTG
$4.4B
| $144K | ﹤0.01% |
+22,400
| New | +$144K |
|
|
THRD
3223
DELISTED
Third Harmonic Bio
THRD
| $143K | ﹤0.01% |
+13,000
| New | +$143K |
|
3224
Zenvia
ZENV
$69.7M
| $143K | ﹤0.01% |
121,200
+31,000
| +34% | +$36.6K |
|
3225
Ocugen
OCGN
$334M
| $142K | ﹤0.01% |
246,173
-674,978
| -73% | -$389K |
|